As NAD+ levels decline with age, symptoms like fatigue, brain fog, and slower metabolism become more noticeable
HH: Investigation, Writing review & editing
Glucagon-like peptide-1 receptor agonists, aka GLP-1 drugs, were originally approved and used for treatment of Type 2 diabetes, with the first product debuting in 2005
PROMOTES DETOXIFICATION: Glutathione conjugation (facilitated by glutathione transferase enzymes) helps contribute to detoxification by binding electrophiles that would otherwise bind to proteins or nucleic acids, resulting in cellular damage
The patience required during this phase pays off with significant health benefits: reduced disease risk, increased energy, better quality of life, and a foundation for long-term metabolic health that can last for decades
Alcohol and GLP-1 Agonists: Potential Interactions Guidelines for Alcohol Use with GLP-1 Agonists Conclusion References What Are GLP-1 Agonists